{"transactions":[{"id":2459268,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":132060,"kind":"person","name":"Michaels Lisa Anne","position":1,"cik":"0001830610","reported_name":"Michaels Lisa Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-23T21:10:51.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":4243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 2, 2021. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on June 2, 2022, subject to continued service."}],"balance_after":22675,"source":{"system":"sec-edgar","filing":"0001179110-21-011226","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911021011226/edgar.xml","form_type":"4"}},{"id":2512220,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":132060,"kind":"person","name":"Michaels Lisa Anne","position":1,"cik":"0001830610","reported_name":"Michaels Lisa Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:26:31.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":1568,"price":38.33,"value":60101.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on November 11, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 9, 2021. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":18432,"source":{"system":"sec-edgar","filing":"0001179110-21-010113","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911021010113/edgar.xml","form_type":"4"}},{"id":2985947,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":132060,"kind":"person","name":"Michaels Lisa Anne","position":1,"cik":"0001830610","reported_name":"Michaels Lisa Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-10T21:28:37.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on November 9, 2020 and is scheduled to vest over four years, with 25% of the shares to vest on November 9, 2021 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through November 9, 2024."}],"balance_after":120000,"derivative":{"exercise_price":30.41,"expiration_date":"2030-11-08","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001179110-20-010969","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020010969/edgar.xml","form_type":"4"}},{"id":2985946,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":132060,"kind":"person","name":"Michaels Lisa Anne","position":1,"cik":"0001830610","reported_name":"Michaels Lisa Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-10T21:28:37.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on November 9, 2021 continuing through November 9, 2024."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001179110-20-010969","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000117911020010969/edgar.xml","form_type":"4"}}]}